Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists
(news.ycombinator.com)
1.
2.
Heart Attack and Stroke Risk Jumps When People Stop Taking GLP-1s
(news.ycombinator.com)
3.
4.
This smartwatch says it can evaluate your diabetes risk without a fingerprick
(androidauthority.com)
5.
The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs
(feeds.nature.com)
7.
A foundation model for continuous glucose monitoring data
(feeds.nature.com)
8.
Heart and Kidney Diseases and Type 2 Diabetes May Be One Ailment
(news.ycombinator.com)
10.
11.
13.
Cannabis use associated with quadrupled risk of developing type 2 diabetes
(news.ycombinator.com)
14.
Gene-edited pancreatic cells transplanted into a patient with type 1 diabetes
(news.ycombinator.com)
15.
CRISPR offers new hope for treating diabetes
(news.ycombinator.com)
16.
CRISPR Offers New Hope for Treating Diabetes
(news.ycombinator.com)
17.
Crispr Offers New Hope for Treating Diabetes
(wired.com)
18.
Ozempic Might Be a Dementia Buster, Too
(gizmodo.com)